Drug Trial Radar · NCT00268814
The German Project of Heroin Assisted Treatment of Opiate Dependent Patients
Last checked: Nov 20, 2026Latest source record: Sep 9, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,015
Actual
Start
Mar 2002
Primary completion
Dec 2003
Study completion Dec 2007
Sponsor
- Lead sponsor
- Universitätsklinikum Hamburg-EppendorfAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Federal Ministry of Health, Germany; State of Northrhine-Westfalia; State of Hessen; State of Lower-Saxony; City of Hamburg; City of Hanover; City of Frankfurt; City of Bonn; City of Cologne; City of Munich
- First posted
- Dec 22, 2005
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 23 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study will test the hypotheses that heroin assisted treatment, compared to methadone maintenance treatment, is more effective with regard to * the improvement of health, * reduction of illicit drug consumption, * decrease of criminal behaviour, * rise in the accessibility and retainment, * detachment from a social drug context, * social stabilisation in the sense of new drug-free contacts, improved vocational circumstances, financial security, stabilisation of the living situation, * enrollment in subsequent treatment in the case of heroin dependent persons who could not be effectively reached or successfully treated so far, and it will check which is the optimal treatment setting with regard to these aims. The medication is injectable pure heroin (diacetylmorphine) 3x/d, or d l methadone 1x/d The study design is multicentre, open, randomised, 4 x 2 stratified. The study duration is 24 months (individual period of investigation), 1. study phase: 12 moths (protocol part B) and 2. study phase: 12 moths (part C). Patients recruited have an opiate dependency according to ICD-10, who are not being treated currently or who are in a methadone maintenance programme with an unsatisfactory course of treatment.
Conditions
- Opioid Dependence
Interventions
DiacetylmorphineDrug
Diacetylmorphine (i.v.), daily
Psycho-education and CounsellingBehavioral
Psycho-educational group therapy and individual counselling
MethadoneDrug
Methadone (p.o.), daily
Case management and Motivational interviewingBehavioral
Individual Case Management combined with Motivational interviewing
Primary outcomes
What the sponsor says the trial is designed to measure.
- (A) Improvement of physical or mental state of health,Time frame: 12 months
- (B) Reduction of consumption of street heroin and no increase of cocaine use.Time frame: 12 months
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
AWO Ambulanz
Karlsruhe, Baden-Wuertenberg, Germany
Heroinambulanz
Munich, Bavaria, Germany
Pro Vivere Drogenambulanz
Hamburg, Free and Hanseatic City of Hamburg, Germany
Studienambulanz
Frankfurt am Main, Hesse, Germany
Drogenambulanz Hannover
Hanover, Lower-Syxony, Germany
Heroinambulanz Bonn
Bonn, Northrhine-Westfalia, Germany
Heroinambulanz Koeln
Cologne, Northrhine-Westfalia, Germany
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.